STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

June 21, 2022

Period of Report

June 17, 2022

Accession Number

0001062993-22-015258